术前血清脂质作为3575例甲状腺乳头状癌患者生存的新预测因素
该回顾性队列纳入2012至2016年3575例甲状腺乳头状癌患者,中位随访56.7个月。术前低甘油三酯(TAG<0.605 mmol/L)和低高密度脂蛋白(HDL<0.935 mmol/L)与复发风险升高独立相关,低TAG组5年无病生存率94.4%低于高TAG组的97.2%。基于独立危险因素构建的列线图对3年和4年无病生存率有临床预测价值。
要点
- 术前低TAG(<0.605 mmol/L)与PTC复发风险升高独立相关(HR 2.20,95%CI 1.30-3.72)。
- 术前低HDL(<0.935 mmol/L)与PTC复发风险升高独立相关(HR 1.60,95%CI 1.00-2.57)。
- 低TAG组5年无病生存率94.4%,低于高TAG组的97.2%(P<.001)。
核心结论
- 术前低TAG和低HDL水平与PTC复发独立相关,术前血清脂质浓度有助于预测PTC患者预后。
研究设计与样本
- 回顾性队列研究,纳入2012至2016年本院收治并随访的3575例甲状腺乳头状癌患者,平均随访56.7个月。
- 术前血清脂质通过受试者工作特征曲线转换为分类变量,采用单因素和多因素Cox回归模型分析,并以独立危险因素构建预测无病生存率的列线图。
主要发现
- 与高TAG(≥0.605 mmol/L)和高HDL(≥0.935 mmol/L)患者相比,低TAG(HR 2.20,95%CI 1.30-3.72)和低HDL(HR 1.60,95%CI 1.00-2.57)患者PTC复发风险显著更高。
- 低TAG组5年无病生存率为94.4%,低于高TAG组的97.2%(P<.001)。
- 胆固醇(P=.13)、低密度脂蛋白(P=.07)和极低密度脂蛋白(P=.15)与PTC复发无统计学相关性。
- 列线图模型在训练队列中3年和4年无病生存率的c-index分别为0.80(95%CI 0.73-0.87)和0.82(95%CI 0.73-0.90),显示临床预测价值。
关键数值与推荐
- 术前TAG以0.605 mmol/L为界值分为低水平和高水平两组。
- 术前HDL以0.935 mmol/L为界值分为低水平和高水平两组。
- 列线图预测3年无病生存率的c-index为0.80(95%CI 0.73-0.87),4年无病生存率的c-index为0.82(95%CI 0.73-0.90)。
临床怎么用
- 作者认为术前血清脂质浓度有助于在临床实践中预测PTC患者的预后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Papillary thyroid cancer (PTC) is an endocrine malignancy with rapidly increased rate. The relationship between lipids and PTC recurrence need further investigate. OBJECTIVE: The objective of this study is to investigate the association between preoperative serum lipids levels and the outcomes of PTC patients. METHODS: A retrospective cohort study including 3575 patients with PTC from 2012 to 2016 with follow-ups in our institute were enrolled. Preoperative serum lipids were divided into categorical variables by receiver operating curves. Univariable and multivariable Cox regression models were developed and independent risk factors were used to construct a nomogram to predict disease-free survival (DFS) rate. RESULTS: Among the 3575 patients, the mean follow-up time was 56.7 months. Comparing with the patients with high levels of triglyceride (TAG ≥ 0.605 mmol/L) and high-density lipoprotein (HDL ≥ 0.935 mmol/L), those with low levels of TAG (hazard ratio [HR] 2.20, 95% CI 1.30-3.72) and HDL (HR 1.60, 1.00-2.57) had a significantly higher risk of recurrence in PTCs. The 5-year DFS rate of patients with low levels of TAG was 94.4%, which was much lower than that in the high-level group (97.2%, P < .001). While cholesterol (P = .13), low-density lipoprotein (P = .07), and very low-density lipoprotein (P = .15) were not statistically correlated with recurrence of PTCs. The nomogram model showed clinical predictive value with a c-index of 0.80 (95% CI 0.73-0.87) and 0.82 (95% CI 0.73-0.90) for 3- and 4-year DFS in the training cohorts. CONCLUSION: In the present study, we provide initial evidence that low levels of TAG and HDL were independently associated with the recurrence of PTC, indicating that preoperative serum concentrations of lipids are helpful in predicting the prognosis for patients with PTC in clinical practice.
引用
- Yuan J, Chen Z, Zhang J, et al. Preoperative Serum Lipids as Novel Predictors of Survival in 3575 Patients With Papillary Thyroid Cancer. J Clin Endocrinol Metab. 2025. PMID: 39210609. doi:10.1210/clinem/dgae601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。